Results 231 to 240 of about 79,407 (254)

Tenofovir-alafenamide/tenofovir-disoproxil-fumarate

Reactions Weekly, 2018
openaire   +1 more source

Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching from Tenofovir Disoproxil Fumarate.

Clinical Gastroenterology and Hepatology, 2021
K. Byun, Jonggi Choi, Ji-hoon Kim, Y. Lee, H. Lee, Y. Kim, B. Yoo, S. Kwon, G. Gwak, Y. Lim   +9 more
semanticscholar   +1 more source

Tenofovir

Reactions Weekly, 2013
  +4 more sources

Tenofovir

Reactions Weekly, 2015
openaire   +1 more source

Tenofovir

Reactions Weekly, 2003
openaire   +2 more sources

Tenofovir

Reactions Weekly, 2019
openaire   +2 more sources

Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis

Gut, 2020
Sung Won Lee, Jung Hyun Kwon, Hae Lim Lee   +2 more
exaly  

Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men

Science Translational Medicine, 2012
Peter L Anderson, David V Glidden, Albert Y Liu   +2 more
exaly  

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Lancet, The, 2015
Paul E Sax, Michael T Yin, Fa Post
exaly  

Tenofovir

Reactions Weekly, 2008
openaire   +2 more sources